<DOC>
	<DOCNO>NCT01935414</DOCNO>
	<brief_summary>This study hypothesise gekoâ„¢ device efficient TEDS prevent formation symptomatic/asymptomatic Deep Vein Thrombosis ( DVTs ) , post-surgery .</brief_summary>
	<brief_title>Geko Neuromuscular Stimulator vs Thromboembolism Deterrent Stockings ( TEDS ) : DVT Prevention Study</brief_title>
	<detailed_description />
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Thromboembolism</mesh_term>
	<mesh_term>Venous Thrombosis</mesh_term>
	<criteria>1 . Aged 18 year age 2 . Free significant abnormal finding determine medical history ( specifically absence DVT haematological disorder ) . 3 . Has use medication ( prescribed overthecounter include herbal remedy ) judge significant Principal Investigator ten ( 10 ) day precede enrolment . 4 . Able understand Patient Information Sheet willing sign write Informed Consent Form . 5 . Able willing follow protocol requirement . 1 . Are require hip revision surgery 2 . History sign previous deep superficial vein thrombosis/pulmonary embolism . 3 . Evidence asymptomatic DVT Duplex Ultrasound 4 . Peripheral arterial disease ( ABPI &lt; 0.8 ) , varicose vein low limb ulceration ischemia . 5 . Significant varicose vein , phlebitis lower limb ulceration ischemia . CEAP Grade 46 . See Appendix 2 6 . Recent surgery within last 3 month ( abdominal , gynaecological , hip knee replacement ) . 7 . Recent trauma lower limb . 8 . Chronic Obesity ( BMI Index &gt; 40kg/m2 ) . 9 . Pregnancy . 10 . Significant history follow disease I. Cardiovascular : Recent MI ( &lt; 6 month ) II . Percutaneous Coronary Intervention ( PCI ) stent ( &lt; 3 month Bare Metal Stent ( BMS ) &lt; 12 month Drug Eluding Stent ( DES ) III . Moderate severe CCF , uncontrolled AF IV . Neurological : Stroke , Hemiplegia/Paraplegia , Myopathies V. Significant dermatological condition affect low limb result broken inflamed skin particularly site device fit . VI . Clinically significant haematological condition i.e . coagulation disorder , sickle cell disease VII . Psychiatric disorder 11 . On LMWH/Heparin ( Prophylactic/therapeutic dos ) Warfarin warfarin stop recently replace LMWH/ Heparin 12 . Long term steroid dermatological change 13 . A pulse rate le 40 beats/minute 14 . A sit systolic blood pressure &gt; 180 &lt; 100 mmHg and/or sit diastolic pressure &gt; 100 mmHg . 15 . Any significant illness four ( 4 ) week precede hip replacement surgery . 16 . Participation clinical study eight ( 8 ) week precede screening period</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>